Literature DB >> 26676843

Conditions for confounding of interactions.

Aihua Liu1,2,3, Michal Abrahamowicz1,2, Jack Siemiatycki3,4.   

Abstract

PURPOSE: Pharmaco-epidemiology increasingly investigates drug-drug or drug-covariate interactions. Yet, conditions for confounding of interactions have not been elucidated. We explored the conditions under which the estimates of interactions in logistic regression are affected by confounding bias.
METHODS: We rely on analytical derivations to investigate the conditions and then use simulations to confirm our analytical results and to quantify the impact of selected parameters on the bias of the interaction estimates.
RESULTS: Failure to adjust for a risk factor U results in a biased estimate of the interaction between exposures E1 and E2 on a binary outcome Y if the association between U and E1 varies depending on the value of E2. The resulting confounding bias increases with increase in the following: (i) prevalence of confounder U; (ii) strength of U-Y association; and (iii) heterogeneity in the association of E1 with U across the strata of E2. A variable that is not a confounder for the main effects of E1 and E2 may still act as an important confounder for their interaction.
CONCLUSIONS: Studies of interactions should attempt to identify-as potential confounders-those risk factors whose associations with one of the exposures in the interaction term may be modified by the other exposure.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  confounding bias; effect modification; interaction; logistic regression; pharmacoepidemiology; simulations

Mesh:

Year:  2015        PMID: 26676843     DOI: 10.1002/pds.3924

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  4 in total

1.  Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.

Authors:  Diane Lacaille; J Antonio Avina-Zubieta; Eric C Sayre; Michal Abrahamowicz
Journal:  Ann Rheum Dis       Date:  2016-12-28       Impact factor: 19.103

2.  The impact of moderator by confounder interactions in the assessment of treatment effect modification: a simulation study.

Authors:  Antonia Mary Marsden; William G Dixon; Graham Dunn; Richard Emsley
Journal:  BMC Med Res Methodol       Date:  2022-04-03       Impact factor: 4.615

3.  Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.

Authors:  Valeria Raparelli; Malik Elharram; Cristiano S Moura; Michal Abrahamowicz; Sasha Bernatsky; Hassan Behlouli; Louise Pilote
Journal:  J Am Heart Assoc       Date:  2020-01-04       Impact factor: 5.501

4.  Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol.

Authors:  Harsukh Benipal; Anne Holbrook; J Michael Paterson; James Douketis; Gary Foster; Lehana Thabane
Journal:  BMJ Open       Date:  2020-09-22       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.